Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has announcements × Small Cell Lung Carcinoma × tremelimumab × Clear all

Phase

Status

Active not recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Non Small Cell Lung Cancer NSCLC 1 Lung Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Etoposide 3 Carboplatin 3 tremelimumab 2 durvalumab 2 atezolizumab 2 PM 01183 2 sacituzumab govitecan 1 pembrolizumab 1 amrubicin 1 Topotecan 1 Cisplatin 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03703297 2025-11-21

ADRIATIC

AstraZeneca

Phase 3 Active not recruiting

730 enrolled 19 charts 1 FDA

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03043872 2025-10-21

CASPIAN

AstraZeneca

Phase 3 Active not recruiting

987 enrolled 42 charts 2 FDA

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡